Inspire Medical (INSP) Takes 32% Nosedive on Dismal Earnings, Outlook

We recently published 10 Big Names Bleed Double Digits. Inspire Medical Systems, Inc. (NYSE:INSP) is one of the worst-performing stocks on Tuesday.

Inspire Medical nosedived by 32.35 percent on Tuesday to end at $87.91 apiece as investors unloaded portfolios following a disappointing earnings performance in the second quarter of the year, coupled with a lower growth outlook for the full year.

This followed the company’s swing to a $3.59 million net loss in the second quarter of the year, reversing a $9.8 million net income in the same period last year.

Revenues, however, jumped by 10.7 percent to $217 million from $195.88 million in the same comparable period.

In the first half, Inspire Medical Systems, Inc. (NYSE:INSP) said it widened its net loss by 183 percent to $600 million from $212 million, while revenues grew by 16 percent to $418 million from $360 million.

Commenting on the company’s performance, Inspire Medical Systems, Inc. (NYSE:INSP) Chairman and CEO Tim Herbert believed that operational headwinds were just temporary and that actions are underway to address them.

Copyright: lenetstan / 123RF Stock Photo

For full-year 2025, the company expects revenues to now settle between $900 million and $910 million, lower than the $940 million to $955 million expected previously.